Webinar – Yasmine Belkaid – Microbiome control of host immunity

Monday 29th August 2022 at Online Webinar

Presenter

Dr. Yasmine Belkaid is a Distinguished Investigator at the National Institute of Allergy and Infectious Diseases at the National Institute of Health (Bethesda). She obtained her Master at USTHB in Algeria and her Ph.D. from the Pasteur Institute in France. Following a postdoctoral fellowship at the National Institute of health (Bethesda) on immune regulation during infection, she started her research program at the Children’s Hospital Research Foundation in Cincinnati. In 2005, she joined the National Institute of Allergy and Infectious Diseases (NIAID) and was appointed senior scientist in 2008. Her laboratory explores fundamental mechanisms that regulate tissue homeostasis and host immune responses and uncovered key roles for the microbiota and dietary factors in the control of immunity and protection to pathogens. Dr Belkaid also holds an appointment at the University of Pennsylvania and is the director of the trans NIH Center for Human immunology. She is the founder and Director of the NIAID Microbiome program. Dr Belkaid is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine and recipient of numerous awards including the Lurie Prize in Biomedical Sciences, the AAI-Thermo Fisher Meritorious Career Award, the Emil von Behring Prize, and the Sanofi-Institut Pasteur Award.

Moderator

Jo-Ann Passmore, PhD, is a Principal Medical Scientist with the National Health Laboratory Services, and Associate Professor in the Division of Medical Virology, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town (UCT). Her research focuses on studying genital tract adaptive and innate immune responses associated with protection from, or susceptibility to, sexually transmitted infections, including HPV and HIV. Her special interests are reproductive tract immunity and STIs/BV, translational approaches to use live biotherapeutics to cure BV, discovery of biomarkers for susceptibility HIV risk, HIV and HPV disease progression and cancer, including the role of secreted inflammatory molecules, genital immune activation and HIV- and HPV-specific immune responses present in the female genital tract in advancing disease pathogenesis.

REGISTER HERE


Event Details


Upcoming Events

19th Vaccine Congress

Sunday 7th September 2025 at Kyoto International Conference Center

ICW 2025 Meeting

Sunday 14th September 2025 at Brisbane Convention & Exhibition CentreInternational Complement Society

XXVI SMI National Congress 2025

Sunday 28th September 2025 at Centro de Exposiciones y Convenciones de Chihuahua. Av. Tecnológico y EscuderoSociedad Mexicana de Inmunologia

8th International Symposium Intra Articular Treatment (ISIAT 2025)

Thursday 2nd October 2025 at Pullman Bucharest World Trade Center 10 Montreal Square

FOCIS European Advanced Course and Conference on Immunology and Immunopathology

Monday 20th October 2025 at University of Rouen Normandy, Faculty of HealthFederation of Clinical Immunology Societies (FOCIS)

5th Conference of the International Society of Fish and Shellfish Immunology

Tuesday 4th November 2025 at Chung-Hwa Hall, The Magic School of Green Technology, NCKUInternational Society of Fish and Shellfish

IPIC2025 – International Primary Immunodeficiencies Congress

Wednesday 5th November 2025 at O2 Universum.

Annual Meeting of the French Society of Immunology – Paris 2025

Wednesday 12th November 2025 at a Cité des Sciences et de l’IndustrieSociété Francaise d'Immunologie

Joint 3rd Qatar International Allergy and Immunology Conference (QIAIC3) and CHOICE Global

Wednesday 12th November 2025 at Le Royal Meridien Place Vendome LusailQatar Allergy and Immunology Society